Skip to content

LENSAR, Inc. LNSR Other Commercial Liabilities

Other Commercial Liabilities at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
Bausch + Lomb logo
Bausch + LombBLCO
IAR
Integra LifeSciencesIART
ITG
Integer HoldingsITGR
Lightpath Technologies logo
Lightpath TechnologiesLPTH
nLIGHT, Inc. logo
nLIGHT, Inc.LASR

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Reported directly by LENSAR, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s other commercial liabilities?
LENSAR, Inc. (LNSR) reported other commercial liabilities of $3.9M in Q1 2026.
How has LENSAR, Inc.'s other commercial liabilities changed year-over-year?
LENSAR, Inc.'s other commercial liabilities decreased by 43.5% year-over-year, from $6.91M to $3.9M.
What is the long-term trend for LENSAR, Inc.'s other commercial liabilities?
Over 5 years (2020 to 2025), LENSAR, Inc.'s other commercial liabilities has grown at a 11.2% compound annual growth rate (CAGR), from $4.57M to $7.77M.